Painreform Ltd (PRFX)

$0.90 -0.03 (-3.71%)
Market Cap 1.87M
Revenue (ttm) 0.00
Net Income (ttm) -14.59M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 54,000
Avg Vol 389,820
Day's Range N/A - N/A
Shares Out 2.01M
Stochastic %K 7%
Beta 0.61
Analysts Strong Buy
Price Target $47.99

Company Profile

PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and pain treatment of hernia repair operatio...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 972 3 7177050
Address:
65 Yigal Alon St., Tel Aviv, Israel
SwingNow
SwingNow Nov. 13 at 8:56 PM
$PRFX trampoline next spiker
0 · Reply
BearTamerTrading
BearTamerTrading Nov. 13 at 7:18 AM
🚀 Premarket Power Plays — Bear Tamer Trading Community Wins 🔥 Part 2/2 Here are the catalysts that sparked today’s moves: 🔥 $BODI — Reported first quarterly net profit since IPO, gross margins jumped to ~74%, strong digital-subscription pivot. 🔥 $CMCT — Announced sale of lending division (~$44M deal), unlocking ~$31M net cash and refocusing on core real-estate assets. 🔥 $BW — Investor momentum from strategic turnaround toward AI-data-center infrastructure, hydrogen, and decarbonization projects. 🔥 $PRFX — Low-float biotech with attention on upcoming PRF-110 milestones and diversification into AI-driven solar analytics. 🔥 $GLTO — Clinical-stage biotech with upcoming IND milestone for GB3226 (oncology), drawing speculative interest. Members were already in position before the volume spike due to timely alerts 💪 If you missed it, watch the replay for proof — testimonials are in the comments ⬇️ 👉 https://www.youtube.com/live/aKG9DgeDqUo?si=9SdTH58Xrih4Rp6x
4 · Reply
Ashamo
Ashamo Nov. 12 at 6:28 PM
$PRFX I just want an $CYPH move!!
0 · Reply
ShadowSnake
ShadowSnake Nov. 12 at 4:30 PM
$PRFX $2 🙏
0 · Reply
CW630
CW630 Nov. 12 at 4:14 PM
$PRFX that phase 3 update will be the big one
1 · Reply
Ashamo
Ashamo Nov. 12 at 4:01 PM
$PRFX $PAINREFORM Ltd big buy order here, catalyst today and phase 3 top line update for PRF 110 due any day now!
0 · Reply
_ReddBullyz
_ReddBullyz Nov. 12 at 3:48 PM
Gotta give it to @Invinc1ble dude’s been on a hot streak 🔥 Worth a follow! $ICG $PRFX $SOL.X $ALGM Track
0 · Reply
Ashamo
Ashamo Nov. 12 at 3:01 PM
$PRFX we need volume and a Ms Tammy pump! Lol
0 · Reply
CoolCatTrades
CoolCatTrades Nov. 12 at 2:56 PM
Made a killing on this guys call, Gave @MomentumZeus a FOLLOW . Insane trader. He called CMCT couple days ago and it just ran 100%+ Wathcing for runs on $PRFX $VCIG $BGLC $AIRE now
0 · Reply
CW630
CW630 Nov. 12 at 2:10 PM
$PRFX also had some NVDA news the other day not sure why it's trading down here.
0 · Reply
Latest News on PRFX
PainReform's DeepSolar Advances Development of its AI-Driven Automated Reporting Engine for Solar-Asset Analysis

Nov 12, 2025, 9:00 AM EST - 2 days ago

PainReform's DeepSolar Advances Development of its AI-Driven Automated Reporting Engine for Solar-Asset Analysis

PainReform's DeepSolar, Developing “DeepSolar Predict” within the NVIDIA Connect Program, Featured in The Market Link's “Watchlist Interview” and Announces Progress Toward Pilot Projects

Nov 5, 2025, 8:30 AM EST - 9 days ago

PainReform's DeepSolar, Developing “DeepSolar Predict” within the NVIDIA Connect Program, Featured in The Market Link's “Watchlist Interview” and Announces Progress Toward Pilot Projects

PainReform Provides Business Update for the Six Months Ended June 30, 2025

Oct 1, 2025, 9:27 AM EDT - 6 weeks ago

PainReform Provides Business Update for the Six Months Ended June 30, 2025

PainReform/DeepSolar Accepted into NVIDIA Connect Program

Aug 19, 2025, 8:30 AM EDT - 3 months ago

PainReform/DeepSolar Accepted into NVIDIA Connect Program

PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System

Aug 13, 2025, 8:30 AM EDT - 3 months ago

PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System

PainReform Ltd. enters into a Strategic Investment Agreement to Expand its Non-Opiate Pain Management Pipeline into Opthamology with LayerBio

Jul 10, 2025, 8:30 AM EDT - 4 months ago

PainReform Ltd. enters into a Strategic Investment Agreement to Expand its Non-Opiate Pain Management Pipeline into Opthamology with LayerBio

Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales

May 27, 2025, 12:12 PM EDT - 6 months ago

Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales

PainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar™ Platform to Optimize One of Romania's Largest Solar Projects

May 7, 2025, 4:30 PM EDT - 6 months ago

PainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar™ Platform to Optimize One of Romania's Largest Solar Projects

PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar's AI-Driven Platform to Address the Growing Solar Optimization Market

Apr 10, 2025, 8:30 AM EDT - 7 months ago

PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar's AI-Driven Platform to Address the Growing Solar Optimization Market

PainReform Provides Year-End Business Update

Apr 7, 2025, 5:00 PM EDT - 7 months ago

PainReform Provides Year-End Business Update

PainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar Analytics

Mar 5, 2025, 11:00 AM EST - 9 months ago

PainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar Analytics

PainReform Executes Definitive Agreement to Acquire DeepSolar, Marking a Unique Expansion Opportunity

Feb 18, 2025, 8:30 AM EST - 9 months ago

PainReform Executes Definitive Agreement to Acquire DeepSolar, Marking a Unique Expansion Opportunity

PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110

Dec 27, 2024, 8:30 AM EST - 11 months ago

PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110

PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial

Nov 20, 2024, 8:30 AM EST - 1 year ago

PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial

PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement

Nov 7, 2024, 5:00 PM EST - 1 year ago

PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement

PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110

Sep 11, 2024, 8:30 AM EDT - 1 year ago

PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110

PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds

Sep 10, 2024, 9:46 AM EDT - 1 year ago

PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds

PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study

Aug 20, 2024, 8:30 AM EDT - 1 year ago

PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study

PainReform Announces Favorable Safety Profile of PRF-110, Indicating Potential for Use in New Surgical Applications Requiring Higher Doses

Aug 7, 2024, 10:00 AM EDT - 1 year ago

PainReform Announces Favorable Safety Profile of PRF-110, Indicating Potential for Use in New Surgical Applications Requiring Higher Doses

PainReform's New Manufacturing Process Achieves Significant Benefits Including 18-Month Stability of PRF-110 at Room Temperature

Aug 1, 2024, 8:30 AM EDT - 1 year ago

PainReform's New Manufacturing Process Achieves Significant Benefits Including 18-Month Stability of PRF-110 at Room Temperature

PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification

May 31, 2024, 4:15 PM EDT - 1 year ago

PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification

PainReform Provides Business Update for the First Quarter of 2024

May 15, 2024, 4:05 PM EDT - 1 year ago

PainReform Provides Business Update for the First Quarter of 2024

PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com

May 8, 2024, 8:30 AM EDT - 1 year ago

PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com

PainReform Announces Closing of $4 Million Public Offering

Apr 18, 2024, 2:19 PM EDT - 1 year ago

PainReform Announces Closing of $4 Million Public Offering

PainReform's Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions

Apr 9, 2024, 9:00 AM EDT - 1 year ago

PainReform's Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions

PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy

Apr 2, 2024, 8:30 AM EDT - 1 year ago

PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy

PainReform to Present at the Microcap Conference in Atlantic City

Jan 22, 2024, 8:30 AM EST - 1 year ago

PainReform to Present at the Microcap Conference in Atlantic City

PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief

Jan 3, 2024, 8:30 AM EST - 2 years ago

PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief

PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds

Dec 26, 2023, 6:00 PM EST - 2 years ago

PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds

PainReform Provides Business Update for the Third Quarter of 2023

Nov 15, 2023, 4:05 PM EST - 2 years ago

PainReform Provides Business Update for the Third Quarter of 2023

PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery Following Positive FDA Review of Drug Master File

Sep 11, 2023, 8:30 AM EDT - 2 years ago

PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery Following Positive FDA Review of Drug Master File

PainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, Hungary

Sep 7, 2023, 10:00 AM EDT - 2 years ago

PainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, Hungary

PainReform to Participate in the H.C. Wainwright 25th Annual Global Investment Conference in New York City

Sep 5, 2023, 8:30 AM EDT - 2 years ago

PainReform to Participate in the H.C. Wainwright 25th Annual Global Investment Conference in New York City

PainReform Provides Business Update for the Second Quarter of 2023

Aug 10, 2023, 4:05 PM EDT - 2 years ago

PainReform Provides Business Update for the Second Quarter of 2023

PainReform Regains Compliance with Nasdaq Continued Listing Requirements

Jul 19, 2023, 9:00 AM EDT - 2 years ago

PainReform Regains Compliance with Nasdaq Continued Listing Requirements

PainReform Announces Pricing of $1.5 Million Concurrent Registered Direct Offering and Private Placement

Jul 14, 2023, 2:35 PM EDT - 2 years ago

PainReform Announces Pricing of $1.5 Million Concurrent Registered Direct Offering and Private Placement

PainReform Announces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private Placement

Jul 12, 2023, 9:05 AM EDT - 2 years ago

PainReform Announces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private Placement

PainReform to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 21st

Jun 15, 2023, 8:30 AM EDT - 2 years ago

PainReform to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 21st

PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery

Jun 7, 2023, 4:30 PM EDT - 2 years ago

PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery

PainReform Provides Business Update for the First Quarter of 2023

May 15, 2023, 4:45 PM EDT - 2 years ago

PainReform Provides Business Update for the First Quarter of 2023

PainReform Announces Positive Safety Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery

May 1, 2023, 8:30 AM EDT - 2 years ago

PainReform Announces Positive Safety Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery

PainReform Completes First Part of Phase 3 Clinical Trial in Patients Undergoing Bunionectomy Surgery

Mar 28, 2023, 9:10 AM EDT - 2 years ago

PainReform Completes First Part of Phase 3 Clinical Trial in Patients Undergoing Bunionectomy Surgery

PainReform Provides Year-End Business Update; Commences Phase 3 Clinical Trial of PRF-110 in Bunionectomy

Mar 16, 2023, 8:00 AM EDT - 2 years ago

PainReform Provides Year-End Business Update; Commences Phase 3 Clinical Trial of PRF-110 in Bunionectomy

PainReform Ltd. (NASDAQ: PRFX) Announces Receipt of Extension to Meet the Nasdaq's Minimum Bid Price Requirement

Feb 7, 2023, 4:05 PM EST - 3 years ago

PainReform Ltd. (NASDAQ: PRFX) Announces Receipt of Extension to Meet the Nasdaq's Minimum Bid Price Requirement

PainReform Provides Business Update for the Third Quarter of 2022

Nov 15, 2022, 8:30 AM EST - 3 years ago

PainReform Provides Business Update for the Third Quarter of 2022

PainReform to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Sep 1, 2022, 8:00 AM EDT - 3 years ago

PainReform to Present at the H.C. Wainwright 24th Annual Global Investment Conference

PainReform Provides Business Update for the Second Quarter of 2022

Aug 16, 2022, 8:05 AM EDT - 3 years ago

PainReform Provides Business Update for the Second Quarter of 2022

PainReform to Present at The Noble Capital Markets' Eighteenth Annual Investor Conference on April 20th

Apr 12, 2022, 9:00 AM EDT - 3 years ago

PainReform to Present at The Noble Capital Markets' Eighteenth Annual Investor Conference on April 20th

PainReform to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th

Mar 21, 2022, 9:25 AM EDT - 3 years ago

PainReform to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th

PainReform Provides Year-End Business Update; on Track to Commence Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief in the Second Half of 2022

Mar 17, 2022, 8:00 AM EDT - 3 years ago

PainReform Provides Year-End Business Update; on Track to Commence Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief in the Second Half of 2022

SwingNow
SwingNow Nov. 13 at 8:56 PM
$PRFX trampoline next spiker
0 · Reply
BearTamerTrading
BearTamerTrading Nov. 13 at 7:18 AM
🚀 Premarket Power Plays — Bear Tamer Trading Community Wins 🔥 Part 2/2 Here are the catalysts that sparked today’s moves: 🔥 $BODI — Reported first quarterly net profit since IPO, gross margins jumped to ~74%, strong digital-subscription pivot. 🔥 $CMCT — Announced sale of lending division (~$44M deal), unlocking ~$31M net cash and refocusing on core real-estate assets. 🔥 $BW — Investor momentum from strategic turnaround toward AI-data-center infrastructure, hydrogen, and decarbonization projects. 🔥 $PRFX — Low-float biotech with attention on upcoming PRF-110 milestones and diversification into AI-driven solar analytics. 🔥 $GLTO — Clinical-stage biotech with upcoming IND milestone for GB3226 (oncology), drawing speculative interest. Members were already in position before the volume spike due to timely alerts 💪 If you missed it, watch the replay for proof — testimonials are in the comments ⬇️ 👉 https://www.youtube.com/live/aKG9DgeDqUo?si=9SdTH58Xrih4Rp6x
4 · Reply
Ashamo
Ashamo Nov. 12 at 6:28 PM
$PRFX I just want an $CYPH move!!
0 · Reply
ShadowSnake
ShadowSnake Nov. 12 at 4:30 PM
$PRFX $2 🙏
0 · Reply
CW630
CW630 Nov. 12 at 4:14 PM
$PRFX that phase 3 update will be the big one
1 · Reply
Ashamo
Ashamo Nov. 12 at 4:01 PM
$PRFX $PAINREFORM Ltd big buy order here, catalyst today and phase 3 top line update for PRF 110 due any day now!
0 · Reply
_ReddBullyz
_ReddBullyz Nov. 12 at 3:48 PM
Gotta give it to @Invinc1ble dude’s been on a hot streak 🔥 Worth a follow! $ICG $PRFX $SOL.X $ALGM Track
0 · Reply
Ashamo
Ashamo Nov. 12 at 3:01 PM
$PRFX we need volume and a Ms Tammy pump! Lol
0 · Reply
CoolCatTrades
CoolCatTrades Nov. 12 at 2:56 PM
Made a killing on this guys call, Gave @MomentumZeus a FOLLOW . Insane trader. He called CMCT couple days ago and it just ran 100%+ Wathcing for runs on $PRFX $VCIG $BGLC $AIRE now
0 · Reply
CW630
CW630 Nov. 12 at 2:10 PM
$PRFX also had some NVDA news the other day not sure why it's trading down here.
0 · Reply
GreedyBastard4Ever
GreedyBastard4Ever Nov. 12 at 2:05 PM
$PRFX
0 · Reply
max315
max315 Nov. 12 at 2:04 PM
$PRFX ok I'm back for the news/pump. Let's see 1.20
1 · Reply
Stock_Catcher
Stock_Catcher Nov. 12 at 2:00 PM
$PRFX PainReform’s DeepSolar Advances Development of its AI-Driven Automated Reporting Engine for Solar-Asset Analysis
1 · Reply
max315
max315 Nov. 11 at 5:33 PM
$PRFX GL on this one. Just de-list it and be done with it.
2 · Reply
max315
max315 Nov. 11 at 2:33 PM
$PRFX could actually move off of $MSPR both micro floats same sector
0 · Reply
max315
max315 Nov. 10 at 4:32 PM
$PRFX Phase 3 update by eoy. Watching.
1 · Reply
max315
max315 Nov. 10 at 3:32 PM
$PRFX Guaranteed some pumpers are watching this but they probably want it lower first.
0 · Reply
max315
max315 Nov. 10 at 2:41 PM
$PRFX yall need ms Tammy to save you here. lol
1 · Reply
Weimanator
Weimanator Nov. 10 at 12:48 AM
$PRFX big week ahead. Get ready for some exciting news 🧐
1 · Reply
GreedyBastard4Ever
GreedyBastard4Ever Nov. 7 at 4:13 PM
$PRFX in and holding for spike
0 · Reply
max315
max315 Nov. 7 at 3:00 PM
$PRFX low float that can move but also know based on last month's business update and market cap this is a huge de-listing risk at these levels. Don't play with what you can't lose. fwiw
0 · Reply
Macdwatcher1
Macdwatcher1 Nov. 6 at 6:52 PM
$PRFX im in at $1.03 i saw this messaged by some people who have lots of followers… they didnt forget about PRFX
2 · Reply